Breaking News Instant updates and real-time market news.

VIVO

Meridian Bioscience

$7.82 /

-0.575 (-6.85%)

07:56
04/02/20
04/02
07:56
04/02/20
07:56

Meridian Bioscience says many clinical trial partners have suspended operations

The company said, "Many of our clinical trial partners have suspended operations, which will likely result in delays for our products in the pipeline. This includes new assays for the revogene and Curian platforms, as well as our new PediaStat system and its initial lead assay. While those new assays were not expected to receive FDA approval and contribute to revenue in fiscal 2020, their ultimate approval and contribution will be delayed, the extent to which remains unknown. For fiscal 2020, we expect this to reduce our R&D spending below our previously communicated amounts. Meridian's outlook on future periods and the aforementioned impacts reflect facts, circumstances and the Company's assumptions as of today. The impacts of COVID-19 are evolving daily and the extent to which COVID-19 impacts Meridian's business, operations, and financial results, including the duration and magnitude of such impacts, will depend on numerous risks , uncertainties and other factors the Company may not be able to accurately predict, including those discussed in the Risk Factors set forth in Meridian's Annual Report on Form 10-K and other reports filed with the U.S. Securities and Exchange Commission."

VIVO Meridian Bioscience
$7.82 /

-0.575 (-6.85%)

05/01/19 Piper Sandler
Meridian Bioscience upgraded to Neutral from Underweight at Piper Jaffray
04/03/19 Baird
Meridian Bioscience price target cut to $14 from $17 at Baird
04/03/19 Canaccord
Meridian Bioscience downgraded to Sell from Hold at Canaccord
04/03/19 Canaccord
Meridian Bioscience downgraded to Sell from Hold at Canaccord

TODAY'S FREE FLY STORIES

Recommendations
Splunk price target raised to $215 from $156 at Argus » 08:28
05/26/20
05/26
08:28
05/26/20
08:28
SPLK

Splunk

$184.37 /

+21.1 (+12.92%)

Argus analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

05/22/20 JMP Securities
Splunk price target raised to $200 from $155 at JMP Securities
05/22/20 JPMorgan
Splunk price target raised to $190 from $174 at JPMorgan
05/22/20 Raymond James
Splunk price target raised to $185 from $140 at Raymond James
05/22/20 Oppenheimer
Splunk price target raised to $190 from $145 at Oppenheimer
SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

Conference/Events
Evofem to hold a pharmaceutical update conference call » 08:25
05/26/20
05/26
08:25
05/26/20
08:25
EVFM

Evofem

$4.98 /

+0.18 (+3.75%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVFM Evofem
$4.98 /

+0.18 (+3.75%)

EVFM Evofem
$4.98 /

+0.18 (+3.75%)

04/16/20 Roth Capital
Roth believes Evofem 'underappreciated' ahead of Phexxi PDUFA date
12/18/19 Roth Capital
Evofem's Amphora getting closer to FDA approval, says Roth Capital
12/11/19 H.C. Wainwright
Evofem price target raised to $11 from $9 at H.C. Wainwright
10/16/19 Cantor Fitzgerald
Evofem assumed with an Overweight at Cantor Fitzgerald
EVFM Evofem
$4.98 /

+0.18 (+3.75%)

Syndicate
Caladrius announces $4.3M registered direct offering priced at-the-market » 08:24
05/26/20
05/26
08:24
05/26/20
08:24
CLBS

Caladrius

$2.08 /

+0.16 (+8.33%)

Caladrius Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

05/22/20 Brookline
Caladrius initiated with a Buy at Brookline
05/18/20 Dawson James
Caladrius downgraded to Neutral from Buy at Dawson James
CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

Recommendations
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink » 08:24
05/26/20
05/26
08:24
05/26/20
08:24
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

06:29 Today Wells Fargo
Regeneron upgraded to Overweight at Wells Fargo on EYLEA Survey
04:44 Today Wells Fargo
Regeneron upgraded to Overweight from Equal Weight at Wells Fargo
05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

Hot Stocks
Driver sends letter to First United Corp shareholders » 08:23
05/26/20
05/26
08:23
05/26/20
08:23
FUNC

First United Corp

$13.75 /

-0.31 (-2.20%)

Driver, one of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUNC First United Corp
$13.75 /

-0.31 (-2.20%)

Syndicate
Outlook Therapeutics announces $16M private placement for ONS-5010 development » 08:23
05/26/20
05/26
08:23
05/26/20
08:23
OTLK

Outlook Therapeutics

$0.74 /

+0.009 (+1.24%)

Outlook Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTLK Outlook Therapeutics
$0.74 /

+0.009 (+1.24%)

OTLK Outlook Therapeutics
$0.74 /

+0.009 (+1.24%)

05/05/20 Brookline
Outlook Therapeutics initiated with a Buy at Brookline
04/14/20 H.C. Wainwright
Outlook's NORSE-1 remaining on track 'comes as a relief,' says H.C. Wainwright
09/11/19 Ladenburg
Outlook Therapeutics initiated with a Buy at Ladenburg
07/18/19 H.C. Wainwright
Outlook Therapeutics initiated with a Buy at H.C. Wainwright
OTLK Outlook Therapeutics
$0.74 /

+0.009 (+1.24%)

Upgrade
Linde plc upgraded to Buy from Hold at Argus » 08:22
05/26/20
05/26
08:22
05/26/20
08:22
LIN

Linde plc

$190.98 /

-2.615 (-1.35%)

Argus analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIN Linde plc
$190.98 /

-2.615 (-1.35%)

LIN Linde plc
$190.98 /

-2.615 (-1.35%)

05/18/20 UBS
Linde plc price target raised to EUR 200 from EUR 190 at UBS
05/06/20 Berenberg
Linde plc price target lowered to EUR 215 from EUR 225 at Berenberg
04/15/20
Fly Intel: Top five analyst upgrades
04/15/20 Bernstein
Linde plc upgraded to Market Perform from Underperform at Bernstein
LIN Linde plc
$190.98 /

-2.615 (-1.35%)

LIN Linde plc
$190.98 /

-2.615 (-1.35%)

LIN Linde plc
$190.98 /

-2.615 (-1.35%)

LIN Linde plc
$190.98 /

-2.615 (-1.35%)

Recommendations
Ciena has 'at least a one-year lead' with Waveserver 5, says Jefferies » 08:22
05/26/20
05/26
08:22
05/26/20
08:22
CIEN

Ciena

$52.81 /

+1.05 (+2.03%)

Jefferies analyst George…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CIEN Ciena
$52.81 /

+1.05 (+2.03%)

CIEN Ciena
$52.81 /

+1.05 (+2.03%)

05/22/20 MKM Partners
Ciena price target raised to $62 from $54 at MKM Partners
05/13/20 B. Riley FBR
Ciena downgraded to Neutral on marco uncertainty at B. Riley FBR
05/13/20 B. Riley FBR
Ciena downgraded to Neutral from Buy at B. Riley FBR
04/16/20 Morgan Stanley
Ciena downgraded to Equal Weight on installation challenges at Morgan Stanley
CIEN Ciena
$52.81 /

+1.05 (+2.03%)

CIEN Ciena
$52.81 /

+1.05 (+2.03%)

CIEN Ciena
$52.81 /

+1.05 (+2.03%)

CIEN Ciena
$52.81 /

+1.05 (+2.03%)

Hot Stocks
Edison Nation acquires 50% interest in Global Clean Solutions » 08:20
05/26/20
05/26
08:20
05/26/20
08:20
EDNT

Edison Nation

$2.34 /

+0.06 (+2.63%)

Edison Nation is pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDNT Edison Nation
$2.34 /

+0.06 (+2.63%)

Hot Stocks
GTT Communications promotes Ernie Ortega to chief revenue officer » 08:19
05/26/20
05/26
08:19
05/26/20
08:19
GTT

GTT Communications

$9.03 /

-0.02 (-0.22%)

GTT announced that Ernie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

Recommendations
Marvell price target raised to $35 from $30 at Susquehanna » 08:19
05/26/20
05/26
08:19
05/26/20
08:19
MRVL

Marvell

$30.13 /

+1.02 (+3.50%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$30.13 /

+1.02 (+3.50%)

MRVL Marvell
$30.13 /

+1.02 (+3.50%)

05/22/20 B. Riley FBR
Marvell price target raised to $34 from $31 at B. Riley FBR
05/21/20 Cowen
Marvell datapoints indicate softness where they participate, says Cowen
05/21/20 Citi
Marvell price target raised to $35 from $31 at Citi
03/27/20 UBS
UBS upgrades Semiconductor Equipment names, sees supply/demand shock priced in
MRVL Marvell
$30.13 /

+1.02 (+3.50%)

MRVL Marvell
$30.13 /

+1.02 (+3.50%)

MRVL Marvell
$30.13 /

+1.02 (+3.50%)

MRVL Marvell
$30.13 /

+1.02 (+3.50%)

Hot Stocks
Enphase collaborates with University of Washington for 100% renewables grid » 08:18
05/26/20
05/26
08:18
05/26/20
08:18
ENPH

Enphase Energy

$56.32 /

-3.63 (-6.06%)

Enphase Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENPH Enphase Energy
$56.32 /

-3.63 (-6.06%)

ENPH Enphase Energy
$56.32 /

-3.63 (-6.06%)

05/14/20
Fly Intel: Top five analyst downgrades
05/14/20 Goldman Sachs
Enphase Energy downgraded to Neutral from Buy at Goldman Sachs
05/06/20 Craig-Hallum
Enphase Energy price target raised to $54 from $43 at Craig-Hallum
05/06/20 Barclays
Enphase Energy price target raised to $80 from $76 at Barclays
ENPH Enphase Energy
$56.32 /

-3.63 (-6.06%)

ENPH Enphase Energy
$56.32 /

-3.63 (-6.06%)

ENPH Enphase Energy
$56.32 /

-3.63 (-6.06%)

Hot Stocks
GTT Communications announces departure of CEO » 08:18
05/26/20
05/26
08:18
05/26/20
08:18
GTT

GTT Communications

$9.03 /

-0.02 (-0.22%)

GTT Communications…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

Recommendations
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim » 08:18
05/26/20
05/26
08:18
05/26/20
08:18
ADMA

ADMA Biologics

$2.84 /

-0.065 (-2.24%)

, GILD

Gilead

$73.31 /

-0.17 (-0.23%)

, MRNA

Moderna

$69.00 /

+1.99 (+2.97%)

Maxim analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADMA ADMA Biologics
$2.84 /

-0.065 (-2.24%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

MRNA Moderna
$69.00 /

+1.99 (+2.97%)

ADMA ADMA Biologics
$2.84 /

-0.065 (-2.24%)

05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
03/16/20 H.C. Wainwright
ADMA Biologics price target lowered to $12 from $14 at H.C. Wainwright
08/12/19 Dawson James
ADMA Biologics downgraded to Neutral from Buy at Dawson James
07/09/19 Jefferies
ADMA Biologics shares 'too cheap' given progress, says Jefferies
GILD Gilead
$73.31 /

-0.17 (-0.23%)

07:02 Today SunTrust
Gilead upgraded to Hold at SunTrust on remdesivir commercial prospects
06:00 Today SunTrust
Gilead upgraded to Hold from Sell at SunTrust
05:02 Today Piper Sandler
Piper Sandler encouraged by remdesivir results published in NEJM
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
MRNA Moderna
$69.00 /

+1.99 (+2.97%)

05/20/20 Morgan Stanley
Moderna price target raised to $90 from $37 at Morgan Stanley
05/19/20 Piper Sandler
Piper trims Moderna target to $100 on capital raise dilution
05/19/20 BMO Capital
Moderna price target raised to $112 from $83 at BMO Capital
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
ADMA ADMA Biologics
$2.84 /

-0.065 (-2.24%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

MRNA Moderna
$69.00 /

+1.99 (+2.97%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

MRNA Moderna
$69.00 /

+1.99 (+2.97%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

MRNA Moderna
$69.00 /

+1.99 (+2.97%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

MRNA Moderna
$69.00 /

+1.99 (+2.97%)

Hot Stocks
Materion, Kairos Power form collaboration to develop supply of salt coolant » 08:17
05/26/20
05/26
08:17
05/26/20
08:17
MTRN

Materion

$50.78 /

-1.23 (-2.36%)

Kairos Power and Materion…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTRN Materion
$50.78 /

-1.23 (-2.36%)

MTRN Materion
$50.78 /

-1.23 (-2.36%)

04/24/20 KeyBanc
Materion upgraded to Overweight from Sector Weight at KeyBanc
04/24/20 KeyBanc
Materion upgraded to Overweight from Sector Weight at KeyBanc
03/02/20 Sidoti
Materion upgraded to Buy following 25% pullback at Sidoti
03/02/20 Sidoti
Materion upgraded to Buy from Neutral at Sidoti
MTRN Materion
$50.78 /

-1.23 (-2.36%)

Hot Stocks
Citius provides free access to Mino-Lok for healthcare providers » 08:17
05/26/20
05/26
08:17
05/26/20
08:17
CTXR

Citius Pharmaceuticals

$0.92 /

+0.0339 (+3.84%)

Citius Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTXR Citius Pharmaceuticals
$0.92 /

+0.0339 (+3.84%)

Hot Stocks
Innovation Pharmaceuticals receives data from PHRI on brilacidin » 08:17
05/26/20
05/26
08:17
05/26/20
08:17
IPIX

Innovation Pharmaceuticals

$0.00 /

+ (+0.00%)

Innovation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IPIX Innovation Pharmaceuticals
$0.00 /

+ (+0.00%)

Hot Stocks
AnPac Bio announces patent titled 'Apparatus for Improved Disease Detection' » 08:15
05/26/20
05/26
08:15
05/26/20
08:15
ANPC

AnPac Bio

$7.72 /

+ (+0.00%)

AnPac Bio-Medical Science…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANPC AnPac Bio
$7.72 /

+ (+0.00%)

ANPC AnPac Bio
$7.72 /

+ (+0.00%)

ANPC AnPac Bio
$7.72 /

+ (+0.00%)

Initiation
Jefferies starts Lyra Therapeutics at Buy with $24 price target » 08:14
05/26/20
05/26
08:14
05/26/20
08:14
LYRA

Lyra Therapeutics

$14.53 /

-0.4 (-2.68%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LYRA Lyra Therapeutics
$14.53 /

-0.4 (-2.68%)

06:30 Today BofA
BofA starts Lyra Therapeutics at Buy with $21 price target
06:05 Today BofA
Lyra Therapeutics initiated with a Buy at BofA
05:21 Today Jefferies
Lyra Therapeutics initiated with a Buy at Jefferies
LYRA Lyra Therapeutics
$14.53 /

-0.4 (-2.68%)

Recommendations
Apple checks suggest four new iPhones this year, says Cowen » 08:14
05/26/20
05/26
08:14
05/26/20
08:14
AAPL

Apple

$318.75 /

+1.83 (+0.58%)

Cowen analyst Krish…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$318.75 /

+1.83 (+0.58%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

05/18/20 Wedbush
Apple yet again caught in U.S./China Tensions, says Wedbush
05/12/20 Wedbush
Apple price target raised to $350 from $335 at Wedbush
05/07/20 Bernstein
Google payments to Apple big, predicated on advertising, says Bernstein
05/06/20 Morgan Stanley
Apple's App Store just had strongest month in 2.5 years, says Morgan Stanley
AAPL Apple
$318.75 /

+1.83 (+0.58%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

Hot Stocks
Turkey bank uses OneSpan's Mobile App Security solution » 08:13
05/26/20
05/26
08:13
05/26/20
08:13
OSPN

OneSpan

$19.45 /

+0.89 (+4.80%)

OneSpan announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OSPN OneSpan
$19.45 /

+0.89 (+4.80%)

OSPN OneSpan
$19.45 /

+0.89 (+4.80%)

05/19/20
Fly Intel: Top five analyst initiations
05/19/20 Needham
OneSpan initiated with a Buy at Needham
05/18/20 Needham
OneSpan initiated with a Buy at Needham
03/27/20 BTIG
OneSpan assumed with a Neutral at BTIG
OSPN OneSpan
$19.45 /

+0.89 (+4.80%)

OSPN OneSpan
$19.45 /

+0.89 (+4.80%)

Hot Stocks
Privet, UPG send letter to Synalloy stockholders regarding board nominees » 08:12
05/26/20
05/26
08:12
05/26/20
08:12
SYNL

Synalloy

$8.92 /

-0.08 (-0.89%)

Privet and UPG…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYNL Synalloy
$8.92 /

-0.08 (-0.89%)

Hot Stocks
Anchiano Therapeutics appoints Stan Polovets as chairman of the board » 08:12
05/26/20
05/26
08:12
05/26/20
08:12
ANCN

Anchiano Therapeutics

$1.12 /

+0.03 (+2.75%)

Anchiano Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANCN Anchiano Therapeutics
$1.12 /

+0.03 (+2.75%)

ANCN Anchiano Therapeutics
$1.12 /

+0.03 (+2.75%)

11/18/19
Fly Intel: Top five analyst downgrades
11/18/19 Baird
Anchiano Therapeutics downgraded to Neutral from Outperform at Baird
11/18/19 Oppenheimer
Anchiano Therapeutics downgraded to Perform from Outperform at Oppenheimer
11/18/19 Ladenburg
Anchiano Therapeutics downgraded to Neutral from Buy at Ladenburg
ANCN Anchiano Therapeutics
$1.12 /

+0.03 (+2.75%)

Hot Stocks
Lightbridge receives Australian patent for nuclear feul assemblies » 08:10
05/26/20
05/26
08:10
05/26/20
08:10
LTBR

Lightbridge

$5.95 /

-0.2 (-3.25%)

Lightbridge Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LTBR Lightbridge
$5.95 /

-0.2 (-3.25%)

Hot Stocks
NV5 Global announces $9M in transportation infrastructure awards » 08:10
05/26/20
05/26
08:10
05/26/20
08:10
NVEE

NV5 Global

$43.23 /

-0.78 (-1.77%)

NV5 Global announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVEE NV5 Global
$43.23 /

-0.78 (-1.77%)

NVEE NV5 Global
$43.23 /

-0.78 (-1.77%)

05/19/20 Sidoti
NV5 Global initiated with a Buy at Sidoti
05/19/20 Sidoti
NV5 Global initiated with a Buy at Sidoti
04/08/20 Maxim
NV5 Global, ABM Industries, Badger Meter cut to Hold at Maxim
04/08/20 Maxim
NV5 Global downgraded to Hold from Buy at Maxim
NVEE NV5 Global
$43.23 /

-0.78 (-1.77%)

NVEE NV5 Global
$43.23 /

-0.78 (-1.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.